These data identify IL11 signaling in TECs as a key pathology for stalled kidney regeneration and reveal IL11 as a potential new therapeutic target for unleashing endogenous repair mechanisms in acute and chronic renal diseases. Here, IL11 is linked to chronic kidney disease.